The Fink Family Office is a single-family office managed by Lord Stanley Fink that invests in early-stage venture capital across fintech, life sciences, deep tech, edtech, proptech, and impact sectors.
Portfolio
2
companies
EnsiliTech
EnsiliTech develops room temperature stabilisation technology for vaccines and biologics.
QV Bioelectronics
QV Bioelectronics builds surgically implanted electric field therapy devices to treat brain tumours.
Stanley Fink
Lord
The pre-seed round was led by Science Angel Syndicate and Fink Family Office to develop cold chain-free vaccine technology.
"Our goal are to make the transportation of vaccines and other life-saving biological materials more efficient and cost-effective while also reducing the carbon footprint of this critical supply chain. We are thrilled to have the support of our investors as we work towards this mission."
The pre-series a financing was led by Science Angel Syndicate and Fink Family Office to support pre-clinical studies for the GRACE implant.
